20/20 BIOLABS, INC. (AIDX) Gross margin 2024–2025
20/20 BIOLABS, INC. (AIDX) gross margin by fiscal year — reported gross profit divided by reported revenue.
29.6%FY2025 · since FY2024: 20.6% → 29.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 29.6% | +9.0 pp |
| FY2024 | 20.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AIDX financial trends
AIDX RevenueAIDX Net incomeAIDX Net marginAIDX Gross profitAIDX Operating incomeAIDX Operating marginAIDX Operating cash flowAIDX Free cash flowAIDX Capital expendituresAIDX Return on equityAIDX Stock buybacksAIDX Dividends paidAIDX Total assetsAIDX Total liabilitiesAIDX Shareholders’ equityAIDX overview →